AND EXCHANGE COMMISSION
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 17, 2010
(Exact name of
registrant as specified in its charter)
(State or other
L Street, N.W., 6th Floor, Washington, D.C.
principal executive offices)
Registrants telephone number, including area code (202) 467-6868
(Former name or
former address, if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
communications pursuant to Rule 425 under the Securities Act (17 CFR
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
o Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
As of March 17,
2010, William P. Angrick, III, our Chairman and Chief Executive Officer,
has entered into a written sales plan pursuant to the guidance specified by Rule 10b5-1
under the Securities Exchange Act of 1934, as amended. In addition, Jaime
Mateus-Tique, a member of our Board of Directors, has amended an existing sales
plan, previously adopted as announced in a Current Report on Form 8-K,
dated December 18, 2006, and previously amended, as announced in a Current
Report on Form 8-K, dated December 18, 2009. Each sales plan is
designed to provide enhanced asset diversification and liquidity and is a
component of each individuals overall tax and financial planning strategy.
each individuals sales plan, a broker-dealer is authorized to sell up to a
specified number of shares of the Companys common stock, par value $0.001 per
share (the Shares), pursuant to the terms and conditions of such individuals
sales plan, including minimum sale price thresholds, unless the plan is
terminated earlier pursuant to its terms.
sales plan calls for the sale of up to 1,000,000 Shares or approximately 13.5%
of the Shares he beneficially owns (excluding options exercisable within 60
days). If the sale of all of the Shares
proposed to be sold under his plan is completed, Mr. Angrick would
continue to beneficially own approximately 6.4 million Shares (excluding
options exercisable within 60 days).
Under Mr. Angricks plan, the maximum number of Shares that may be
sold in a single trading day is 10,000 Shares. The sales plan previously
entered into by Mr. Angrick, as announced in a Current Report on Form 8-K,
dated July 10, 2009, has been terminated following the sale of all shares
to be sold under that plan.
to Mr. Mateus-Tiques sales plan adds an additional 450,000 Shares or
approximately 17% of the Shares he beneficially owns (excluding options
exercisable within 60 days) to the sales plan.
Under Mr. Mateus-Tiques plan, the maximum number of Shares that
may be sold in a single trading day is 14,000 Shares. If the sale of all of the Shares proposed to
be sold under his sales plan is completed, Mr. Mateus-Tique would continue
to beneficially own approximately 1.6 million Shares (excluding options exercisable
within 60 days). This Share amount does
not reflect sales that may occur under a sales plan previously entered into by Mr. Mateus-Tique,
as announced in a Current Report on Form 8-K, dated September 12,
2007, which sales plan remains in effect, or otherwise. Under both of Mr. Mateus-Tiques sales
plans, the maximum aggregate number of Shares that may be sold in a single
trading day is 25,000 Shares.
plan has been approved pursuant to the terms of the Companys policies. All sales under these sales plans will be
disclosed publicly as required through Form 144 and Form 4 filings
with the Securities and Exchange Commission.
Company executives and directors may from time to time adopt 10b5-1 plans.